Overview

Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer

Status:
Completed
Trial end date:
2002-08-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining biological therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of biological therapy plus chemotherapy in treating patients with metastatic or recurrent kidney cancer.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of New Mexico
Collaborator:
National Cancer Institute (NCI)
Treatments:
Aldesleukin
Fluorouracil
Interferon-alpha
Interferons
Isotretinoin